BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gentry CA, Campbell DL, Williams RJ. Outcomes associated with recent guideline recommendations removing metronidazole for treatment of non-severe Clostridioides difficile infection: a retrospective, observational, nationwide cohort study. Int J Antimicrob Agents 2021;57:106282. [PMID: 33465458 DOI: 10.1016/j.ijantimicag.2021.106282] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Adelman MW, Goodenough D, Sefton S, Mackey C, Thomas S, Fridkin SK, Woodworth MH. Changes in treatment of community-onset Clostridioides difficile infection after release of updated guidelines, Atlanta, Georgia, 2018. Anaerobe 2021;70:102364. [PMID: 33862203 DOI: 10.1016/j.anaerobe.2021.102364] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Najjar-Debbiny R, Bazazhina A, Schwartz N, Shaked P, Saliba W, Weber G. Non-inferiority of metronidazole to vancomycin in the treatment of first episode non-severe Clostridioides difficile infection: a single center retrospective cohort study. Infection 2022. [PMID: 35192148 DOI: 10.1007/s15010-022-01778-y] [Reference Citation Analysis]